{
    "patient": {
        "Name": "Megan Nguyen",
        "DateOfBirth": "1984-04-09",
        "Sex": "Female",
        "Diagnosis": "Squamous cell carcinoma",
        "BodyPart": "Skin",
        "Physician": "Dr. Joshua Navarro",
        "TreatingInstitution": "Delgado Ltd"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Skin",
            "CollectedDate": "2023-08-01",
            "ReceivedDate": "2023-08-06",
            "TumorPercentage": "53%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2023-08-04",
            "ReceivedDate": "2023-08-07"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "CDKN2A",
                "DNA Alteration": "c.89C>T",
                "GeneMutation": "p.V51D Frameshift-LOF",
                "VariantAlleleFraction": "3.48%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "FGFR2",
                "DNA Alteration": "c.1124A>G",
                "GeneMutation": "p.V679F Spliceregionvariant-LOF",
                "VariantAlleleFraction": "11.12%"
            },
            {
                "Gene": "CALR",
                "DNA Alteration": "c.1092_1143del52",
                "GeneMutation": "p.N549K Frameshift-LOF",
                "VariantAlleleFraction": "16.65%"
            },
            {
                "Gene": "U2AF1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.Q157X Spliceregionvariant-LOF",
                "VariantAlleleFraction": "22.15%"
            },
            {
                "Gene": "STAT5B",
                "DNA Alteration": "c.1924A>C",
                "GeneMutation": "p.K659E Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "5.23%"
            },
            {
                "Gene": "EGFR",
                "DNA Alteration": "c.2375T>A",
                "GeneMutation": "p.L718X Frameshift-LOF",
                "VariantAlleleFraction": "12.69%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "PTPN11",
            "FGFR3",
            "ARID2",
            "MET"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "48 m/Mb",
            "Tmbpercentile": "96%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "Stable"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}